Interestingly, in melanoma cells, preventing FAK activity or inhibiting paxillin binding to FAK reduces cell migration and prevents cell-associated proteolytic activity, but paradoxically increases invadopodia structure formation (Mousson et al., 2021). The gene discussed is PTK2; the disease is melanoma.